June Sherie Almenoff - 02 Sep 2026 Form 4 Insider Report for Actinium Pharmaceuticals, Inc. (ATNM)

Reporting relationship: Director
Issuer ticker: ATNM
Reported as of: 02 Sep 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Sep 2026, 17:00:28 UTC
Prior SEC filing: 13 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ June Almenoff

Filing notes and source

Key filing fact

June Sherie Almenoff filed Form 4 for Actinium Pharmaceuticals, Inc. (ATNM) on 04 Sep 2026.

Key facts

This page summarizes June Sherie Almenoff's Form 4 filing for Actinium Pharmaceuticals, Inc. (ATNM).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 04 Sep 2026, 17:00.

Change

Previous filing in this sequence was filed on 13 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001492647 Primary reporting owner

Almenoff June Sherie

Relationship: Director
Address: C/O ACTINIUM PHARMACEUTICALS, INC., 100 PARK AVE., 23RD FLOOR, NEW YORK
Signature: /s/ June Almenoff
Signature date: 04 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ATNM transaction

Common Stock

Award

Transaction value
Shares: +18,000
Change %
Price: $0.000000^*
Shares after: 18,000
Date: 02 Sep 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ATNM transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +27,000
Change %
Price: $0.000000^*
Shares after: 27,000
Date: 02 Sep 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 27,000
Exercise price: $1.00
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

Represents a grant of restricted stock units ("RSUs"). The RSUs vest as follows: 1/3 on the first anniversary of the date of grant, 1/3 on the second anniversary of the date of grant and 1/3 on the third anniversary of the date of grant.

Footnote F2

The stock options vest and become exercisable in fifty equal monthly tranches beginning on the date of grant.